News | January 12, 2023
Genome sequencing solutions will help to bring precision in lung cancer therapy, says GlobalData
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
NDM disorders are a group of rare, inherited neuromuscular disorders with an estimated prevalence of 1 case per 100,000 inhabitants in Spain, and are characterized by the inability to relax muscles following voluntary contraction (myotonia)
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
The new project further expands the partner's long-term collaboration on new technologies for R&D
He urged the dignitaries to collaboratively work on the identified domains of improvement and make detailed reports on them
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
